Inflammatory bowel disease (IBD) is the name for a group of conditions that involve chronic inflammation of the digestive tract. Crohn’s disease and ulcerative colitis are the two most common types of IBD.
UT Southwestern Medical Center’s Crohn’s and Colitis Program is the first of its kind in Texas. It features a collaborative team of gastroenterologists, colorectal surgeons, pathologists, imaging specialists, and nurses, as well as basic science researchers who continually seek new information about the nature of these diseases and new ways to improve treatment outcomes for patients.
Inflammation of the intestinal tract, which often leads to ulcers, fistulae, or obstructions, characterizes IBD. Crohn’s disease can affect any part of the gastrointestinal (GI) tract, from the mouth to the anus, while ulcerative colitis strikes the inner lining of the large intestine or the rectum.
Without proper management of these diseases, patients can suffer from abdominal pain, anemia, diarrhea, weight loss, malnutrition, and cancer.